- Research Research
-
Care and Services
- Care and Services
- ABA Therapy Program
- School Consultation Program
- Appointments and Referrals
- Assessment and Diagnosis
- Severe Behavior Program
- Multidisciplinary Feeding Program
- Language and Learning Program
- Louise and Brett Samsky Preschool
- Medical Services
- Family Support and Care Coordination
- Therapeutic Services
- Resources Resources
-
Training
- Training
- Crisis Prevention Program
- Educational Programs
- Outreach Programs
- Training and Outreach Team
- Get Involved Get Involved
Clinical Trials Lab
The Clinical Trials Lab at Marcus Autism Center develops and tests pharmacological and behavioral interventions for children with autism spectrum disorder (ASD).
Current studies
- Efficacy of the Direct Instruction Language for Learning Program to Promote Expressive and Receptive Language in Children with ASD
- Leucovorin for the Treatment of Language Impairment in Children with ASD
- Measuring Sleep Problems in Children with ASD
Recent accomplishments
The randomized phase of the Direct Instruction Language for Leaning study is now completed. 83 children ages 4 to 7 participated. Half the children in the Direct Instruction group findings showed improvement in the use of language compared to 25% in the children in the community treatment control condition. On a commonly used language test, both groups improved. The Direct Instruction group did slightly better than the control group.
In late 2019, Lawrence Scahill, PhD, MSN, Director of Clinical Trials at Marcus Autism Center and colleagues from Ohio State University and Children's Hospital of Philadelphia published a report on a new parent-rated scale for anxiety in children with ASD (PRAS-ASD). This scale is now being used in several clinics in the U.S. and Europe.
Contact information
Rebecca Kilbourne
404-785-1883
Faculty members and collaborators